Remarks : Pathophysiology of Hypertension and its Relation to the Choice of Antihypertensive Treatment
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人日本循環器学会の論文
- 1981-07-20
著者
-
Ikeda Masao
National Cardiovascular Center, Department of Cardiology
-
Omae Teruo
Kyushu Univ.
-
Ikeda Masao
National Cardiovascular Center
関連論文
- CLINICAL FEATURE OF ACUTE MYOCARDIAL INFARCTION WITH REFERENCE TO PRE-INFARCTION AND POST-INFARCTION ANGINA : PROCEEDINGS OF THE 47th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY : Ischemic Heart Disease (I)
- Significance of Symptomatological Diagnosis and Treatment of Angina Pectoris Developing into Acute Myocardial Infarction : Unstable Angina
- CORRELATION BETWEEN SODIUM INTAKE AND HOME BLOOD PRESSURE IN ESSENTIAL HYPERTENSION : Hypertension (II) : 46th Annual Scientific Meeting, Japanese Circulation Society
- SEQUENTIAL CHANGES OF LEFT VENTRICULAR FUNCTION AND ST SEGMENT DEVIATION IN VASOSPASTIC ISCHEMIA : Ichemic Heart Disease (II) : 46th Annual Scientific Meeting, Japanese Circulation Society
- CORRELATION OF ST SEGMENT DEVIATION AND THE DEGREE OF LUMINAL NARROWING DUE TO CORONARY ARTERY SPASM DURING ANGINAL ATTACK : Ischemic heart disease : FREE COMMUNICATIONS (Abstract) : 45 Annual Scientific Meeting, Japanese Circulation Society
- 127. Studies on Brain Circulation (VI) : (1) Basilar Blood Flow in Renoprival Dogs : (2) Studies on Brain Circulation in Patients with Cerebral Vascular Accidents by External Counting Method Using RISA
- Studies on Brain Circulation (V) : Basilar Blood Flow in Experimental Renal Hypertensive Dogs
- Studies on Brain Circulation (IV) : Experimental Analysis of the Significance of the Basilar Blood Flow : PROCEEDINGS OF THE 25TH ANNUAL MEETlNG, JAPANESE CIRCULATION SOCIETY Part III
- Remarks : Pathophysiology of Hypertension and its Relation to the Choice of Antihypertensive Treatment
- VASOACTIVE DRUGS AND REGIONAL BLOOD FLOW : USEFULNESS OF THE RADIOACTIVE MICROSPHERE METHOD IN RATS : PROCEEDINGS OF THE 47th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY : Cardiovascular Drugs (II)